NCT05328752 Safety and Tolerability Study of XXB750 in Heart Failure Participants With Reduced or Mildly Reduced Ejection Fraction (HFrEF/HFmrEF) Status COMPLETED Phase PHASE1
NCT05320159 Treatment Effectiveness Among Psoriasis Patients Treated With Cosentyx (Secukinumab) Status COMPLETED Phase N/A
NCT05305664 A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Rate of Weekly Lipoprotein Apheresis Sessions in Patients With Hyperlipoproteinemia(a) and Established Cardiovascular Disease in Germany Status COMPLETED Phase PHASE3
NCT05304949 Regulatory PMS Study for Lucentis® in Patients With Retinopathy of Prematurity Status COMPLETED Phase N/A
NCT05301907 Survey Among Healthcare Professionals and MS Patients to Assess Their Understanding of RMP Materials Status COMPLETED Phase N/A
NCT05294289 Health-related Quality of Life, Symptom Severity, and Pain Among Patients With PIK3CA-related Overgrowth Spectrum: A Mixed-methods Observational Study Status COMPLETED Phase N/A
NCT05285904 Kesimpta® (Ofatumumab) in Swiss Multiple Sclerosis Patients - an Observational Study Status COMPLETED Phase N/A
NCT05275868 Study of MGY825 in Patients With Advanced Non-small Cell Lung Cancer Status TERMINATED Phase PHASE1
NCT05275855 First in Human Study to Assess the Safety, Tolerability and Pharmacokinetics of EDI048 in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT05274425 A 24-week rPMS Study in Real-world Setting for Enerzair Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05272059 Multiple Ascending Dose Study of MHS552 in Adults With Type 1 Diabetes Mellitus Status WITHDRAWN Phase PHASE1
NCT05269966 Study to Evaluate the Safety and Effectiveness of Intravitreal Injections (IVI) of Brolucizumab in Patients With Neovascular Age-related Macular Degeneration (nAMD) Status COMPLETED Phase PHASE4
NCT05269771 MAP to Provide Access to Ruxolitinib, for Patients With Polycythemia Vera Status NO_LONGER_AVAILABLE Phase N/A
NCT05268289 Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V Status RECRUITING Phase PHASE2
NCT05266495 Effectiveness of Brolucizumab in Pre-treated Patients With nAMD in the Real-world Setting Status TERMINATED Phase N/A
NCT05266469 Exploring the Profiles of RMS Patients on Ofatumumab or Ocrelizumab in a Real-World Setting in the Gulf Status COMPLETED Phase N/A
NCT05252585 A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma (TSC-AML) Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT05237713 Efficacy and Safety of Canakinumab for the Treatment of Anemia in LR-MDS Patients Status TERMINATED Phase PHASE2
NCT05236530 Drug-drug Interaction Study of Ganaplacide and Lumefantrine With Midazolam, Repaglinide, Dextromethorphan, Metformin, Rosuvastatin and Dolutegravir Status COMPLETED Phase PHASE1